Financial statements Centralpharm Lewandowska
Balance sheet of Centralpharm Lewandowska
Company age:
Age:
23 y. 8 m. 18 d.
Balance sheet data of CENTRALPHARM LEWANDOWSKA
|
Year
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|
| Total assets | 4 248 574,90 | 4 746 883,27 | 6 783 204,43 | 7 523 405,30 | 9 622 377,91 |
| A. Fixed assets | 1 650,00 | 28 043,33 | 25 593,33 | 23 143,33 | 20 843,33 |
| B. Current assets | 4 246 924,90 | 4 718 839,94 | 6 757 611,10 | 7 500 261,97 | 9 601 534,58 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 4 248 574,90 | 4 746 883,27 | 6 783 204,43 | 7 523 405,30 | 9 622 377,91 |
| A. Equity | -1 341 340,80 | -574 289,83 | -285 100,43 | -630 756,94 | 126 499,96 |
| B. Liabilities and provisions for liabilities | 5 589 915,70 | 5 321 173,10 | 7 068 304,86 | 8 154 162,24 | 9 495 877,95 |
| I. Long-term liabilities | 559 500,02 | 2 682 258,90 | 3 200 000,00 | 4 400 000,00 | 4 900 000,00 |
| II. Short-term liabilities | 5 030 415,68 | 2 638 914,20 | 3 868 304,86 | 3 754 162,24 | 4 595 877,91 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.